a)
An increase in the ionisation of a molecule in a GI environment will usually
increase its solubility. Valproic acid is an oral dosage form used in epilepsy and
has a pKa of 4.8. With the stomach pH at 2.0 and the ileum at pH 6.8, which area
of the GIT will Valproic acid be more soluble.
b)
You are required to manufacture 1L of 50mM pH 7.0 phosphate buffer that could be
used for an injectable formulation of valproic acid. The Ka of dihydrogen phosphate is
6.3x10
-8
and the RMM of potassium dihydrogen phosphate and dipotassium
hydrogen phosphate are 136 and 174 respectively.
I.
Calculate the pKa of dihydrogen phosphate.
II.
What is the ratio between the conjugate base and the acid to be used?
III.
Calculate the mass of anhydrous potassium dihydrogen phosphate and
dipotassium hydrogen phosphate with RMM of 136 and 174, and
concentrations of 30.5 and 19.5 mmol respectively.
a) pH = pKa + log10{[A-]/[HA]}
Stomach (pH = 2.0)
2.0 = 4.8 + log10{[A-]/[HA]}
-2.8 = log10{[A-]/[HA]}
2.8 = log10{[HA]/[A-]}
631x + x = [A]total
99.84% is protonated and 0.16% is unprotonated
Ileum (pH = 6.8)
6.8 = 4.8 + log10{[A-]/[HA]}
2.0 = log10{[A-]/[HA]}
100x + x = [A]total
99.00% is unprotonated and 1.00% is protonated
In stomach Valproic acid is more soluble
b) I. pKa = -log10 Ka = -log10 (6.3×10-8) = 7.2
II. pH = pKa + log{[A-]/[HA]}
[HA] + [A-] = 0.05
7.0 = 7.2 + log{(0.05-x)/x}
x/(0.05 - x) = 1.58
x = 0.0306
[HA] = 0.0306 mol
[A-] = 0.0194 mol
[A-]/[HA] = 1.577
III. For molecular weights: KH2PO4 = 39 + 97 = 136 amu; K2HPO4 = 39×2 + 96 = 174 amu
Thus, 0.0306×136 = 4.161 g of KH2PO4 and 0.0194×174 = 3.376 g of K2HPO4 should be added.
Comments
Leave a comment